If you come from a South Asian background you are at a higher risk of developing Type 2 diabetes. Diabetes is serious but the good news is that there are a number of ways you can reduce your risk of ...
More and more people are choosing to follow a vegetarian diet for many different reasons. It’s estimated that two per cent of the population now don’t eat meat or fish. Reasons for switching to a ...
2023 - TREND UK press release Trend UK has published an insulin safety leaflet. The patient booklet is entitled Keeping Safe with Insulin Therapy because “insulin management and prescribing errors are ...
Try adding 2-3 cloves garlic with the leek. No need to crush them as you’re blending the dish. To give this soup a rich green colour and an extra portion of vegetables, add a handful of defrosted ...
There are some very early clues to suggest that coronavirus might be triggering type 1 or type 2 diabetes in some people, or making the condition worse for others. We take a look at the evidence and ...
Scientists in the United States have announced early results from a pioneering trial testing a new stem cell treatment designed to replace insulin-producing beta cells in people with type 1 diabetes.
Devastating diabetes complications costs the UK healthcare system £6.2 billion a year, which highlights not just the seriousness of diabetes but also the importance of getting the right care to people ...
We're going to explore whether an intermittent fasting diet can help you put your type 2 diabetes into remission. What are intermitten ...
Update, 14 August 2025: The Medicines and Healthcare products Regulatory Agency (MHRA) has licensed teplizumab as the first-ever immunotherapy for type 1 diabetes in the UK. Read our news story to ...
Causes of type 1 diabetes It’s normal to wonder if something you’ve done could have caused your type 1 diabetes – or a child’s type 1 diabetes. But there’s nothing you could have done to prevent it.
The first ever immunotherapy for type 1 diabetes has been licensed for use in the UK. The Medicines and Healthcare products Regulatory Agency (MHRA) has decided teplizumab, also known as Tzield, is ...
The Shift-Diabetes research team at King’s College London is working to understand more about how night work influences diet and blood sugar levels in people living with type 2 diabetes. Our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results